via Carnegie Mellon University
Carnegie Mellon University researchers reveal fastest known COVID-19 antibody test with high sensitivity due to a unique, 3D printing technology and an electrochemical reaction.
Researchers at Carnegie Mellon University, in collaboration with the University of Pittsburgh and UPMC, have developed one of the fastest known COVID-19 antibody tests. The test results are available in 10 to 15 seconds and detect the presence of two of the antibodies to SARS-CoV-2, the virus responsible for COVID-19. Such a quick and effective test could be a game-changer for controlling the spread of the pandemic.
The breakthrough test would require a very small drop of blood from a fingertip (less than five microliters) to identify two antibodies of the virus: spike S1 protein and receptor binding domain (RBD). It can detect antibody concentrations at an extremely low level, one picomolar (0.15 nanograms per milliliter), through an electrochemical reaction within a handheld microfluidic device. Results are sent almost immediately to a simple interface on a smart phone. The device can be cleaned (i.e. regenerated) within one minute using a special chemistry discovered by the researchers that allows multiple, successive readings from the same device.
A simple yet elegant additive manufacturing technology called aerosol jet 3D printing is responsible for the efficiency and accuracy of this testing device. Tiny, inexpensive gold micropillar electrodes are printed at nanoscale using aerosol droplets that are thermally sintered together. This causes a rough, irregular surface that provides increased surface area of the micropillars and an enhanced electrochemical reaction, where antibodies can latch on to antigens coated on the electrode. The specific geometry allows the micropillars to load more proteins for detection, resulting in very accurate, quick results.
“This sensing platform can also be used to detect other infectious diseases, potentially affecting the course of pandemics.”
RAHUL PANAT, ASSOCIATE PROFESSOR, DEPARTMENT OF MECHANICAL ENGINEERING
The test has a very low error rate since the binding reaction between the antibody and antigen used in the device is highly selective. This natural design was exploited by the researchers to their advantage.
The device, which has a provisional patent, is inexpensive to make (in the tens of dollars). And, the manufacturing capabilities already exist.
“My research team was working on 3D printed high-performance sensors to detect dopamine, a chemical in brain, when we realized that we could adapt our work for COVID-19 testing,” said?Rahul Panat, an associate professor of mechanical engineering at Carnegie Mellon who uses specialized additive manufacturing techniques for research ranging from brain-computer interfaces to biomonitoring devices. “We shifted our research to apply our expertise to combatting this devastating pandemic.”
Knowing the work would require a multidisciplinary approach, Panat collaborated with Shou-Jiang Gao, leader of the Cancer Virology Program at UPMC Hillman Cancer Center and professor of microbiology and molecular genetics at the University of Pittsburgh. Azahar Ali, a postdoctoral researcher in Panat’s Advanced Manufacturing and Materials Lab, was the lead author of the study. Their research findings are available on MedRxiv in anticipation of peer review.
“We’re sharing these results at the time of preprint and prior to peer review because of the significant, potential impact on public health,” said Panat.
This sensing platform can also be used for the detection of other infectious diseases.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 Antibody Test
- UK man tests personalised melanoma vaccine
A man in England is among the first in the world to receive a personalised vaccine, which scientists hope will protect against skin cancer. Stevenage man Steve Young, 52, is one of many skin cancer ...
- Evotec Biologics Unveils J.CHO™ High Expression System for Enhanced Antibody Production
Evotec Biologics, the biologics arm of Evotec SE, has introduced its proprietary J.CHO™ High Expression System for antibody expression. J.CHO™ optimizes biotherapeutic production processes by ...
- Scientists report longest known ‘extreme’ Covid infection in 72-year-old man
Doctors reported the case of a 72-year-old patient in the Netherlands who suffered from the novel coronavirus infection for 613 days, marking the longest SARS-CoV-2 infection duration to date. They ...
- COVID Shot Boosts Mucosal Immunity in Previously Infected People
COVID-19 mRNA vaccines stimulated mucosal immunity in people previously infected with SARS-CoV-2, but generated only a tiny amount of immunity in people who had never been infected, according to a ...
- VDH: COVID cases keep declining
CDC states that already an estimated 97% of Americans have some level of immunity, from either vaccination or infection or both, which they said will help keep down new transmission and lessen serious ...
Go deeper with Google Headlines on:
COVID-19 Antibody Test
[google_news title=”” keyword=”COVID-19 Antibody Test” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19 Test
- Bangladesh reports 10 more COVID-19 cases in 24hrs
Bangladesh reported 10 more COVID-19 cases in 24 hours till Saturday morning.With the new numbers, the country's total COVID-19 caseload rose to 20, 49, 955, according to the Directorate General of ...
- National test scores reveal US students losing proficiency in history and civics
Study.com used data from The Nation’s Report Card to explore declining test scores for history and civics subjects in the U.S.
- Covid-19 Found in People’s Blood Months After Infection
A quarter of people had Covid-19 viral proteins in their blood up to 14 months after infection. These proteins in the blood indicate that SARS-CoV-2 keeps living in tissue reservoirs. The study used a ...
- Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
- MTA suspends 11 Long Island Rail Road workers for submitting fake COVID-19 vaccination cards issued by Julie DeVuono
Investigators had a list of MTA employees claiming they were vaccinated by Amityville nurse practitioner Julie DeVuono, officials said.
Go deeper with Google Headlines on:
COVID-19 Test
[google_news title=”” keyword=”COVID-19 Test” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]